To strengthen the analysis, they examined 450 K methylation array data for KEAP1 in an independent cohort of 481 ccRCC patients, finding a strong association between KEAP1 promoter hypermethylation and higher tumor grading and staging. This evidence concerns the gene KEAP1 and neoplasm.